THU0431 Sustained Improvements in Skin Symptoms, Physical Functioning, and Quality of Life with Secukinumab versus Ustekinumab in Patients with Moderate-To-Severe Psoriasis and Concomitant Psoriatic Arthritis: 52 Week Results from The Clear Study
Gottlieb, A.B., Thaçi, D., Blauvelt, A., Bhosekar, V., Milutinovic, M., Karyekar, C.Volume:
75
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2016-eular.2650
Date:
June, 2016
File:
PDF, 207 KB
english, 2016